736
Participants
Start Date
November 30, 2010
Primary Completion Date
October 31, 2012
Study Completion Date
December 31, 2012
Certolizumab Pegol (CZP)
"400 mg subcutaneous injection at Weeks 0, 2 and 4~200 mg subcutaneous injection every two weeks, Week 6 through Week 52"
137, Birmingham
166, Huntsville
165, Peoria
216, Tucson
168, Hot Springs
241, Jonesboro
153, Little Rock
111, Covina
208, Escondido
103, Fullerton
155, Huntington Beach
202, La Mesa
203, Loma Linda
233, Los Angeles
105, Palm Desert
229, Roseville
113, Sacramento
127, San Diego
106, Santa Maria
172, Santa Monica
212, Upland
231, Van Nuys
158, Whittier
121, Bridgeport
200, Bridgeport
107, Danbury
195, Danbury
138, Hamden
218, Lewes
108, Aventura
120, Dunedin
101, Ocala
225, Orange Park
227, Ormond Beach
184, Palm Harbor
145, Sarasota
191, Tampa
236, Vero Beach
144, Atlanta
232, Atlanta
157, Lawrenceville
217, Coeur d'Alene
206, Idaho Falls
193, Rock Island
207, Springfield
186, Elizabethtown
204, Lexington
230, Louisville
149, Cumberland
237, Hagerstown
197, Wheaton
118, Mansfield
132, Worcester
140, Lansing
226, Petoskey
114, Saint Clair Shores
188, Bridgeton
109, St Louis
133, St Louis
124, Lincoln
205, Reno
159, Lebanon
189, Nashua
143, Clifton
125, Albuquerque
175, Albany
139, Binghamton
116, Brooklyn
167, Brooklyn
196, Johnson City
174, New York
104, Orchard Park
135, Plainview
215, Rochester
178, Charlotte
210, Durham
234, Hickory
102, Monroe
152, Bethlehem
112, Duncansville
219, Erie
128, Philadelphia
147, Sellersville
213, Willow Grove
235, Wyomissing
198, Charleston
228, Columbia
130, Hendersonville
129, Jackson
162, Amarillo
110, Austin
156, Austin
192, Dallas
185, El Paso
122, Houston
170, Houston
123, Mesquite
115, Nassau Bay
117, San Antonio
119, San Antonio
161, San Antonio
190, Victoria
142, Waco
136, Burlington
146, Arlington
150, Chesapeake
223, Kennewick
134, Spokane
221, Clarksburg
194, Glendale
Lead Sponsor
UCB Pharma
INDUSTRY